2717 |
Evolution in AAA Endograft Devices, Technique, and Outcomes |
Woong Chol Kang |
May. 08. 14 |
2716 |
Resonable Ways to Care Lower Extremity Disease |
John R. Laird |
May. 08. 14 |
2715 |
Think Big! Beyond Intervention: Supervised Exercise |
Michael R. Jaff |
May. 08. 14 |
2714 |
Strong Supporter for Lumen Patency: Clear Long-term Efficacy of DES |
Mark W. Burket |
May. 08. 14 |
2713 |
Make Plaque Lean: Currenlty Wide Applicable Atherectomy |
Ravish Sachar |
May. 08. 14 |
2712 |
Leave Nothing: Growing Evidence of DEB |
Gian Battista Danzi |
May. 08. 14 |
2711 |
Raising the Standard in Treating Bifurcation Lesions - AxxessTM |
Bryan Ping-Yen Yan |
May. 08. 14 |
2710 |
6-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of 2nd Generation DES with Biolimus Versus Zotarolimus: Prospective, Randomized, Multicenter Trial |
Byoung Kwon Lee |
May. 08. 14 |
2709 |
15-year Temporal Change of LM Revascularization: Lesson from Asan Main Registry |
Seung-Jung Park |
May. 08. 14 |
2708 |
Long-term Follow-up in 1,528 Left Main PCI Patients from a Large Single Center Experience |
Bo Xu |
May. 08. 14 |